Adjuvant chemotherapy

Xem 1-15 trên 15 kết quả Adjuvant chemotherapy

The result of adjuvant vinorelbine plus cisplatin in completely resected stage IB-IIIA non-small cell lung cancer at Hanoi Medical University Hospital

Assess clinical, subclinical characteristics of stage IB-IIIA non - small cell lung cancer patients (NSCLC). Evaluating the result of adjuvant vinorelbine plus cisplatin in completely resected stage IB - IIIA NSCLC.

6p vinatisu 29-08-2024 2 0 Download

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: A real-world study

Pegylated liposomal doxorubicin (PLD) is an improved formulation of doxorubicin with comparable effectiveness but significantly lower cardiotoxicity than conventional anthracycline. This study aimed to evaluate the real-world effectiveness and safety of PLD versus epirubicin as neoadjuvant or adjuvant treatment for breast cancer.

11p vielonmusk 21-01-2022 13 1 Download

Neoadjuvant chemotherapy and radiotherapy followed by resection/ ablation in stage IV rectal cancer patients with potentially resectable metastases

The optimal treatment of stage IV rectal cancer remains controversial. The purpose of this study was to assess the treatment outcomes and toxicity of neoadjuvant chemotherapy and radiotherapy followed by local treatment of all tumor sites and subsequent adjuvant chemotherapy in stage IV rectal cancer patients with potentially resectable metastases.

10p vielonmusk 21-01-2022 13 1 Download
Summary of PhD thesis in Medicine: Research of neo-adjuvant TC chemotherapy regimen result and expression rates of some markers related to tongue cancer at stages III and IV (M0)

Evaluation of response rate and side effects of pre-operative and/or pre-radiotherapy neo-adjuvant TC chemotherapy regimen for treatment of tongue cancer at stages III and IV (M0). Determination of expression rates of p53, EGFR and Her2 markers and some factors related to overall survival of patient with stages III and IV tongue cancer.

25p angicungduoc6 21-07-2020 27 3 Download
Báo cáo khoa học: "Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4)"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4)

7p matuot_238 13-10-2011 61 3 Download
Báo cáo khoa học: "Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy

7p matuot_238 12-10-2011 59 5 Download
báo cáo khoa học: "Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study

7p hoami_238 11-10-2011 46 5 Download
Phiến Huyết Nhỏ Thấp (Thrombocytopenia)

Bệnh nhân caucasian, đàn bà, 79 tuổi khoẻ mạnh trước đây, chỉ uống thuốc giảm cholesterol. Bà ta là bnhân cuả bạn trong 6 năm qua. Chồng bà ta nay đã 80 tuổi, cách đây 15 năm, tìm ra ung thư ruột già, surgeon gửi sang sau khi cắt bỏ ung thư, bạn cho adjuvant chemotherapy 15 năm nay, không thấy ung thư trở lại ... Cách đây 6 năm, Ông xin bạn nhận làm BS điều trị cho vợ cuả ông ta, vì BS điều trị của bà ấy vừa mất. Nể là vợ của bnhân, cho nên...

4p nganluong111 14-04-2011 53 4 Download
Case Records of the Massachusetts General Hospital

Case records of the Massachusetts General Hospital: A 77-year old man with recurrent transitional-cell carcinoma of the Ureter. (Mass Gen'l là teaching hosp chính cuả Harvard Med School, các nhà thương kia là Brigham Women's, New Engl Deaconess hosp) (Bài này từ Hem-Onc section, Dept Internal Medicine; Dept Urology, Radiology, Pathology Mass General và Harvard Med). Đây là một trường hợp khó, 8 năm trước b.

8p sinhtobo111 13-04-2011 42 2 Download
Med.: Reglan

Bệnh nhân này cách đây sáu năm khi trình bệnh (initial presentation) lúc tiên khởi ở stage 2 (T3N0M0) (xem bảng TNM đính kèm trong thư trước) . Ở giai đoạn (stage) này thì median survival ở 5 năm vào khoảng 50 % sống sót. Vấn đề adjuvant chemotherapy: ở thời điểm đó vẫn còn controversial (có nhiều ý kiến khác nhau): (a) có nên cho adjuvant chemotherapy hay không? (b) nếu cho thì cho thuốc gì? Về điểm (a): Bệnh nhân này tương đối còn trẻ vậy nên nghĩ về việc cho hơn là không cho, quyết định này...

4p sinhtobo111 13-04-2011 27 2 Download
Chapter 089. Pancreatic Cancer (Part 5)

Figure 89-2 Survival by adjuvant chemotherapy. Kaplan-Meier estimates of survival from the European Study Group for Pancreatic Cancer 1 (ESPAC1) trial for the comparison of adjuvant chemotherapy versus no adjuvant chemotherapy (CT) in patients with resected pancreatic cancer (hazard ratio for death, 0.71; 95% confidence interval, 0.55 to 0.92; p = .009). (Reprinted with permission from JP Neoptolemos, DD Stocken, H Friess, et al: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210, 2004.

5p konheokonmummim 03-12-2010 68 4 Download
Chapter 086. Breast Cancer (Part 11)

Chemotherapy Unlike many other epithelial malignancies, breast cancer responds to multiple chemotherapeutic agents, including anthracyclines, alkylating agents, taxanes, and antimetabolites. Multiple combinations of these agents have been found to improve response rates somewhat, but they have had little effect on duration of response or survival. The choice among multidrug combinations frequently depends on whether adjuvant chemotherapy was administered and, if so, what type.

5p konheokonmummim 03-12-2010 69 3 Download
Chapter 086. Breast Cancer (Part 9)

One approach—so-called neoadjuvant chemotherapy—involves the administration of adjuvant therapy before definitive surgery and radiation therapy. Because the objective response rates of patients with breast cancer to systemic therapy in this setting exceed 75%, many patients will be "downstaged" and may become candidates for breast-conserving therapy. However, overall survival has not been improved using this approach.

5p konheokonmummim 03-12-2010 77 4 Download
Chapter 086. Breast Cancer (Part 8)

Table 86-3 Suggested Approaches to Adjuvant Therapy Age Group h Lymp Endocr Tum tion Recommenda Node ine Receptor or (ER) Status Statusa Premenopa usal ve Positi Any Any Multidrug chemotherapy tamoxifen positive if + ER+ trastuzumab in HER- 2/neu tumors positive Premenopa usal ive Negat Any 2 Multidrug + ER+ cm, or 1–2 chemotherapy cm with tamoxifen if other poor positive prognostic trastuzumab in HERvariables 2/neu tumors positive Postmenopa usal ve Positi e Negativ Any Multidrug chemotherapy + trastuzumab in HER2/neu tumors positive Postmenopa usal ve Pos...

5p konheokonmummim 03-12-2010 311 3 Download
Chapter 085. Neoplasms of the Lung (Part 13)

Table 85-5 Randomized Studies of Adjuvant Chemotherapy in NSCLC Stu dy Treatment mber Nu of Year 5edian M zard Ha Value p Patients Survival Survival Ratio (%) (95% CI) EC OG Surgery 242 9% 246 3 39 months vs. 0.9 3 (0.74– .56 0 3590 →RT vs. Surgery + post-op concurrent (II–IIIA) 38 1.18) 3 RT + cis/etoposide 3% months AL Surgery 603 1% 606 5 R N 6 0.9 (0.8– .59 0 PI (I–IIIA) alone vs. Surgery + post-op mitomycin/vindesin e/cisplatin 3% 4 1.1) Big Surgery 189 33 months 1.0 2 (0.77– .90 1.35) 0 Lung Trial alone vs.

4p konheokonmummim 03-12-2010 130 5 Download